Gatifloxacin and Ethionamide as the Foundation for Therapy of Tuberculosis

The use of gatifloxacin (GAT) in combination with ethionamide (ETA) with or without pyrazinamide (PZA) for a 12-week treatment period followed by an 8-week observation period was evaluated in a model of tuberculosis in mice. Mice treated with GAT at 300 mg/kg of body weight in combination with ETA (...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Cynamon, Michael H., Sklaney, Mary
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2003
Aiheet:	Experimental Therapeutics
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166105/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878502/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2442-2444.2003
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!